Overcoming obstacles to developing new analgesics

被引：166

作者：

Woolf, Clifford J. ^{[1
,2
,3
]}

机构：

[1] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA

[2] Childrens Hosp, Program Neurobiol, Dept Neurol, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA

来源：

NATURE MEDICINE | 2010年 / 16卷 / 11期

基金：

美国国家卫生研究院;

关键词：

TRIALS IMMPACT RECOMMENDATIONS; OF-FUNCTION MUTATIONS; CHRONIC PAIN; NEUROPATHIC PAIN; CENTRAL SENSITIZATION; GTP CYCLOHYDROLASE; PLACEBO ANALGESIA; SODIUM-CHANNEL; IN-VIVO; PREGABALIN;

D O I：

10.1038/nm.2230

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Despite substantial investment by the pharmaceutical industry over several decades, there has been little progress in developing new, efficacious and safe analgesics. As a result, many large pharmaceutical companies are leaving the area of pain medication. Nevertheless, the chances of success could increase if analgesic drug development strategy changed. To achieve such a paradigm shift we must understand why development of drugs for pain relief is so challenging.

引用

页码：1241 / 1247

页数：7

共 58 条

[21] Contributions of Different Modes of TRPV1 Activation to TRPV1 Antagonist-Induced Hyperthermia [J].

Garami, Andras ;

Shimansky, Yury P. ;

Pakai, Eszter ;

Oliveira, Daniela L. ;

Gavva, Narender R. ;

Romanovsky, Andrej A. .

JOURNAL OF NEUROSCIENCE, 2010, 30 (04) :1435-1440

[22] Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations [J].

Goldberg, Y. P. ;

MacFarlane, J. ;

MacDonald, M. L. ;

Thompson, J. ;

Dube, M-P ;

Mattice, M. ;

Fraser, R. ;

Young, C. ;

Hossain, S. ;

Pape, T. ;

Payne, B. ;

Radomski, C. ;

Donaldson, G. ;

Ives, E. ;

Cox, J. ;

Younghusband, H. B. ;

Green, R. ;

Duff, A. ;

Boltshauser, E. ;

Grinspan, G. A. ;

Dimon, J. H. ;

Sibley, B. G. ;

Andria, G. ;

Toscano, E. ;

Kerdraon, J. ;

Bowsher, D. ;

Pimstone, S. N. ;

Samuels, M. E. ;

Sherrington, R. ;

Hayden, M. R. .

CLINICAL GENETICS, 2007, 71 (04) :311-319

[23] Emotion Recollected in Tranquility: Lessons Learned from the COX-2 Saga [J].

Grosser, Tilo ;

Yu, Ying ;

FitzGerald, Garret A. .

ANNUAL REVIEW OF MEDICINE, 2010, 61 :17-33

[24] Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome [J].

Haeuser, Winfried ;

Petzke, Frank ;

Sommer, Claudia .

JOURNAL OF PAIN, 2010, 11 (06) :505-521

[25] Assessment and Management of Acute Pain in Adult Medical Inpatients: A Systematic Review [J].

Helfand, Mark ;

Freeman, Michele .

PAIN MEDICINE, 2009, 10 (07) :1183-1199

[26] Why most published research findings are false [J].

Ioannidis, JPA .

PLOS MEDICINE, 2005, 2 (08) :696-701

[27] Pharmacology and treatment of neuropathic pains [J].

Jensen, Troels S. ;

Madsen, Caspar S. ;

Finnerup, Nanna B. .

CURRENT OPINION IN NEUROLOGY, 2009, 22 (05) :467-474

[28] Persistent postsurgical pain: risk factors and prevention [J].

Kehlet, H ;

Jensen, TS ;

Woolf, CJ .

LANCET, 2006, 367 (9522) :1618-1625

[29] The Development of New Analgesics Over the Past 50 Years: A Lack of Real Breakthrough Drugs [J].

Kissin, Igor .

ANESTHESIA AND ANALGESIA, 2010, 110 (03) :780-789

[30] Progress in Genetic Studies of Pain and Analgesia [J].

LaCroix-Fralish, Michael L. ;

Mogil, Jeffrey S. .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2009, 49 :97-121

← 1 2 3 4 5 6 →